LH stock

Is Laboratory Corporation of America Holdings (LH) undervalued? · P/E 23, rev $13.01B

Laboratory Corporation of America Holdings (LH) is a diagnostics & research company listed on US.

This page asks whether Laboratory Corporation of America Holdings (LH) looks cheap on cached numbers — not a DCF toy and not a buy alert.

Latest reported LH revenue for 2024-12-31 was $13.01B. Net income was $747.1M. Revenue was up 7.0% from 2023-12-31 to 2024-12-31. LH currently screens at market cap $21.07B and trailing P/E 22.8.

LH currently screens at market cap $21.07B and trailing P/E 22.8. Cheap versus history or peers still needs a filing reason; a low multiple can be a value trap.

A new LH 10-Q can flip this screen overnight. The SEC page is the source.

Not investment advice. Compare LH to the stock page model before you treat a low multiple as a gift.

Not investment advice.

Full LH analysis